Fong To

发表

Increased Inflammation in Atherosclerotic Lesions of Diabetic Akita-LDLr −/− Mice Compared to Nondiabetic LDLr −/− Mice

J. Nilsson, Maria F. Gomez, D. Engelbertsen, 2012, Experimental diabetes research.

IL-25 Inhibits Atherosclerosis Development in Apolipoprotein E Deficient Mice

H. Björkbacka, J. Nilsson, I. Ljungcrantz, 2015, PloS one.

Lack of the Cysteine Protease Inhibitor Cystatin C Promotes Atherosclerosis in Apolipoprotein E–Deficient Mice

J. Nilsson, S. Jovinge, E. Bengtsson, 2005, Arteriosclerosis, thrombosis, and vascular biology.

Inhibition of Nuclear Factor of Activated T-Cells (NFAT) Suppresses Accelerated Atherosclerosis in Diabetic Mice

P. Spégel, J. Nilsson, Maria F. Gomez, 2013, PloS one.

Interleukin-25 (IL-25) has a protective role in atherosclerosis development in the aortic arch in mice

H. Björkbacka, J. Nilsson, I. Ljungcrantz, 2018, The Journal of Biological Chemistry.

Immune responses against aldehyde-modified laminin accelerate atherosclerosis in Apoe-/- mice.

H. Björkbacka, J. Nilsson, D. Engelbertsen, 2010, Atherosclerosis.

Immunization of apoE-/- mice with aldehyde-modified fibronectin inhibits the development of atherosclerosis.

H. Björkbacka, J. Nilsson, G. N. Fredrikson, 2011, Cardiovascular research.

Activation of immune responses against the basement membrane component collagen type IV does not affect the development of atherosclerosis in ApoE-deficient mice

I. Gonçalves, J. Nilsson, D. Engelbertsen, 2019, Scientific Reports.

Absence of the protease inhibitor cystatin C in inflammatory cells results in larger plaque area in plaque regression of apoE-deficient mice.

L. Wittgren, J. Nilsson, S. Jovinge, 2005, Atherosclerosis.

Increased aldehyde-modification of collagen type IV in symptomatic plaques--a possible cause of endothelial dysfunction.

I. Gonçalves, J. Nilsson, A. Edsfeldt, 2015, Atherosclerosis.

Reduced oxidized LDL in T2D plaques is associated with a greater statin usage but not with future cardiovascular events

M. Orho-Melander, I. Gonçalves, J. Nilsson, 2020, Cardiovascular Diabetology.

Interleukin-1 receptor accessory protein blockade limits the development of atherosclerosis and reduces plaque inflammation

I. Bot, H. Björkbacka, D. Liberg, 2024, Cardiovascular research.